Serial biopsy results in prostate cancer screening study

Journal of Urology

Volumn 167, Issue 6, 2002, Pages 2435-2439

  Roehl, Kimberly A ^a   Antenor, Jo Ann V ^a   Catalona, William J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biopsy; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

EID: 0036090461     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64999-3     Document Type: Article

References (22)

1. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values
2. Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: Who should undergo a repeat biopsy?
3. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels
4. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
5. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng./ml. and benign prostate examination
6. Grading errors in prostatic needle biopsies: Relation to the accuracy of tumor grade in predicting pelvic lymph node metastases
7. Nonpalpable stage T1c prostate cancer: Prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings
8. Importance of posterolateral needle biopsies in the detection of prostate cancer
9. The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer
10. Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: A retrospective study
11. A prospective randomized trial comparing 6 versus 12 prostatic biopsy cores: Impact on cancer detection
12. Diagnosis of prostate cancer: Optimal number of prostate biopsies related to serum prostate-specific antigen and findings on digital rectal examination
13. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial
14. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate
15. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies
16. Prediction of significant cancer in men with stage T1c adenocarcinoma of the prostate
17. Distinguishing clinically important from unimportant prostate cancers before treatment: Value of systematic biopsies
18. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies
19. Cancer surveillance series: Interpreting trends in prostate cancer - Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
20. Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates
21. Total PSA cutoff of 2.5 ng./ml. correlates with favorable pathologic features of prostate cancer
22. Evaluation of current AUA prostate cancer screening guidelines